The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial
BMC Medicine
Duloxetine lowers refractory chronic cough
Duloxetine reduced cough frequency and improved cough-related quality of life versus placebo in adults with refractory chronic cough. *Randomized double-blind placebo-controlled trial; Level 1b (OCEBM).
- Level of evidence
- Level 1b (OCEBM)
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
